Leonie I Kroeze

8PUBLICATIONS
43CO-AUTHORS
Molecular targetsPredictive and prognostic markersHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Nov 01, 2025
Molecular reflex testing in patients with early metastatic castration-resistant prostate cancer within the PROMPT-study.

Iris S H Kloots, Peter H J Slootbeek, Sofie H Tolmeijer

|Oct 14, 2025
Challenges in predicting outcomes for watch and wait follicular lymphoma patients: insights into clinical, pathological, and molecular factors.

Eva A M Hesius, James P Stewart, Leonie I Kroeze

|Oct 09, 2025
Analysis of myeloid neoplasms with isolated trisomy 19 reveals a novel MDS subgroup characterized by the presence of ring sideroblasts, fibrosis and SRSF2 and/or ASXL1 mutations.

Konnie M Hebeda, Ludmila Boudová, Maarten F Corsten

|Aug 08, 2023
A significant proportion of classic Hodgkin lymphoma recurrences represents clonally unrelated second primary lymphoma.

Diede A G van Bladel, Wendy B C Stevens, Leonie I Kroeze

|Jun 22, 2023
Cross-Resistance between Platinum-Based Chemotherapy and PARP Inhibitors in Castration-Resistant Prostate Cancer.

Peter H J Slootbeek, Iris S H Kloots, Inge M van Oort

|Dec 11, 2022
Immunological and Genomic Analysis Reveals Clinically Relevant Distinctions between Angiosarcoma Subgroups.

Stefan G van Ravensteijn, Yvonne M H Versleijen-Jonkers, Melissa H S Hillebrandt-Roeffen

Pageof 2

Frequent Collaborators

2 joint publications

Mark A J Gorris

2 joint publications

Konnie M Hebeda

2 joint publications

Niven Mehra

2 joint publications

Patricia J T A Groenen